USANA Health Sciences, Inc.
Cash Flow Statement
| Line Item | FY2016 | FY2015 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $100.0M | $76.6M | $79.0M | $66.4M | $50.8M | $33.6M |
| Depreciation & Amortization | $13.5M | $8.8M | $9.0M | $8.8M | $8.5M | $7.1M |
| Depreciation | $11.9M | $8.4M | $8.2M | $7.7M | $7.4M | — |
| Amortization | $1.5M | $431.0K | $897.0K | $1.1M | $1.5M | — |
| Stock-Based Compensation | $16.5M | $9.8M | $7.6M | $10.2M | $10.5M | $8.9M |
| Net Cash from Operating Activities | $136.9M | $105.2M | $98.9M | $92.8M | $70.1M | $32.5M |
| Investing Activities | ||||||
| Capital Expenditures | $32.7M | $20.4M | $8.1M | $8.4M | $10.6M | $4.1M |
| Business Acquisitions | — | — | — | — | $42.7M | — |
| Net Cash from Investing Activities | $-31.9M | $-16.3M | $-21.6M | $-8.3M | $-10.6M | $-3.2M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | $64.6M | $138.8M | $18.1M | $68.3M | $33.5M | $1.7M |
| Net Cash from Financing Activities | $-64.9M | $-113.0M | $-10.2M | $-64.5M | $-33.4M | $-29.5M |
| Net Change in Cash | $32.6M | $-26.2M | $66.5M | $20.5M | $26.1M | $377.0K |
| Free Cash Flow | $104.2M | $84.8M | $90.8M | $84.4M | $59.5M | $28.3M |